New data provided evidence that, when FFAR2 and FFAR3 expression was reduced, increased levels of glucose transporter 1 (GLUT1), with the subsequent increase in glucose uptake, was observed in the HCT116 CRC cell line (Al Mahri et al., 2020). This evidence concerns the gene FFAR2 and colorectal carcinoma.